4.5 Article

Anaphylactic reaction to probiotics. Cow's milk and hen's egg allergens in probiotic compounds

期刊

PEDIATRIC ALLERGY AND IMMUNOLOGY
卷 23, 期 8, 页码 778-784

出版社

WILEY
DOI: 10.1111/j.1399-3038.2012.01338.x

关键词

anaphylaxis; cow's milk proteins; hen's egg proteins; food allergy; hidden allergens; probiotics

向作者/读者索取更多资源

Background: Probiotics are used in the treatment of allergic diseases. We investigated the safety of probiotics for subjects with food allergy. Material and methods: Labels of probiotics commercially available in Spain were examined to assess their content of cows milk or hens egg. Skin prick tests with these compounds (20 mg/ml) were performed in five children allergic to cows milk, five children allergic to hens white egg, and five control subjects non-allergic to food. Three serum pools: I (positive-specific IgE to cows milk and hens egg white proteins), II (positive-specific IgE to cows milk and negative to hens egg white proteins), and III (negative-specific IgE to cows milk and positive to hens egg white proteins) were used to detect cows milk and hens egg white allergens in probiotics. ImmunoCAP (R) (Phadia), in-house ELISA, SDS-PAGE immunoblotting, and inhibition studies of these assays were performed. Proteins were quantified by enzyme-immunoassay. Results: Eleven probiotics were studied. No label advertised about egg content, eight labels warned about lactose, lactic acid or cows milk, one label claimed to be milk-free, and two gave no information. Cows milk proteins were detected, by at least one lab technique, in 10/11 probiotics, three over 2.5 mg/kg (21, 52, 112 mg/kg). Hens egg white proteins were detected in 3/11 probiotics, only one had more than 2.5 mg/kg (47 mg/kg). Conclusion: Probiotic compounds may contain hidden allergens of food and may not be safe for subjects with allergy to cows milk or hens egg.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey

Anette Bygum, Teresa Caballero, Anete S. Grumach, Hilary J. Longhurst, Laurence Bouillet, Werner Aberer, Andrea Zanichelli, Jaco Botha, Irmgard Andresen, Marcus Maurer, A. S. Grumach, A. Bygum, C. Blanchard Delaunay, I Boccon-Gibod, L. Bouillet, B. Coppere, A. Du Thanh, C. Dzviga, O. Fain, B. Goichot, A. Gompel, S. Guez, P. Y. Jeandel, G. Kanny, D. Launay, H. Maillard, L. Martin, A. Masseau, Y. Ollivier, A. Sobel, E. Aygoeren-Puersuen, M. Bas, M. Bauer, K. Bork, J. Greve, M. Magerl, I Martinez-Saguer, M. Maurer, U. Strassen, E. Papadopoulou-Alataki, F. Psarros, Y. Graff, S. Kivity, A. Reshef, E. Toubi, F. Arcoleo, M. Bova, M. Cicardi, P. Ma Nconi, G. Marone, V Montinaro, M. Triggiani, A. Zanichelli, M. L. Baeza, T. Caballero, R. Cabanas, M. Guilarte, D. Hernandez, C. Hernando de Larramendi, R. Lleonart, T. Lobera, L. Marques, B. Saenz de San Pedro, J. Bjorkander, C. Bethune, T. Garcez, H. J. Longhurst

CLINICAL AND TRANSLATIONAL ALLERGY (2019)

Letter Allergy

Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

Marcus Maurer, Aberer Werner, Rosana Agondi, Mona Al-Ahmad, Maryam Ali Al-Nesf, Ignacio Ansotegui, Rand Arnaout, Luisa Karla Arruda, Riccardo Asero, Emel Aygoeren-Puersue, Aleena Banerji, Andrea Bauer, Moshe Ben-Shoshan, Alejandro Berardi, Jonathan A. Bernstein, Stephen Betschel, Carsten Bindslev-Jensen, Mojca Bizjak, Isabelle Boccon-Gibod, Konrad Bork, Laurence Bouillet, Henrik Balle Boysen, Nicholas Brodszki, Sigurd Broesby-Olsen, Paula Busse, Thomas Buttgereit, Anette Bygum, Teresa Caballero, Regis A. Campos, Mauro Cancian, Ivan Cherrez-Ojeda, Danny M. Cohn, Celia Costa, Timothy Craig, Paulo Ricardo Criado, Roberta F. Criado, Dorottya Csuka, Joachim Dissemond, Aurelie Du-Thanh, Luis Felipe Ensina, Ragip Ertas, Jose E. Fabiani, Claudio Fantini, Henriette Farkas, Silvia Mariel Ferrucci, Ignasi Figueras-Nart, Natalia L. Fili, Daria Fomina, Atsushi Fukunaga, Asli Gelincik, Ana Gimenez-Arnau, Kiran Godse, Mark Gompels, Margarida Goncalo, Maia Gotua, Richard Gower, Anete S. Grumach, Guillermo Guidos-Fogelbach, Michihiro Hide, Natalia Ilina, Naoko Inomata, Thilo Jakob, Dario O. Josviack, Hye-Ryun Kang, Allen Kaplan, Alicja Kasperska-Zajac, Constance Katelaris, Aharon Kessel, Andreas Kleinheinz, Emek Kocaturk, Mitja Kosnik, Dorota Krasowska, Kanokvalai Kulthanan, M. Sendhil Kumaran, Jose Ignacio Larco Sousa, Hilary J. Longhurst, William Lumry, Andrew MacGinnitie, Markus Magerl, Michael P. Makris, Alejandro Malbran, Alexander Marsland, Inmaculada Martinez-Saguer, Iris V. Medina, Raisa Meshkova, Martin Metz, Iman Nasr, Jan Nicolay, Chikako Nishigori, Isao Ohsawa, Kemal Ozyurt, Nikolaos G. Papadopoulos, Claudio A. S. Parisi, Jonathan Grant Peter, Wolfgang Pfuetzner, Todor Popov, Nieves Prior, German D. Ramon, Adam Reich, Avner Reshef, Marc A. Riedl, Bruce Ritchie, Heike Rockmann-Helmbach, Michael Rudenko, Andac Salman, Mario Sanchez-Borges, Peter Schmid-Grendelmeier, Faradiba S. Serpa, Esther Serra-Baldrich, Farrukh R. Sheikh, William Smith, Angele Soria, Petra Staubach, Urs C. Steiner, Marcin Stobiecki, Gordon Sussman, Anna Tagka, Simon Francis Thomsen, Regina Treudler, Solange Valle, Martijn van Doorn, Lilian Varga, Daniel O. Vazquez, Nicola Wagner, Liangchun Wang, Christina Weber-Chrysochoou, Young-Min Ye, Anna Zalewska-Janowska, Andrea Zanichelli, Zuotao Zhao, Yuxiang Zhi, Torsten Zuberbier, Ricardo D. Zwiener, Anthony Castaldo

ALLERGY (2020)

Correction Allergy

The International/Canadian Hereditary Angioedema Guideline (vol 15, 72, 2019)

Stephen Betschel, Jacquie Badiou, Karen Binkley, Rozita Borici-Mazi, Jacques Hebert, Amin Kanani, Paul Keith, Gina Lacuesta, Susan Waserman, Bill Yang, Emel Aygoeren-Puersuen, Jonathan Bernstein, Konrad Bork, Teresa Caballero, Marco Cicardi, Timothy Craig, Henriette Farkas, Anete Grumach, Connie Katelaris, Hilary Longhurst, Marc Riedl, Bruce Zuraw, Magdelena Berger, Jean-Nicolas Boursiquot, Henrik Boysen, Anthony Castaldo, Hugo Chapdelaine, Lori Connors, Lisa Fu, Dawn Goodyear, Alison Haynes, Palinder Kamra, Harold Kim, Kelly Lang-Robertson, Eric Leith, Christine McCusker, Bill Moote, Andrew O'Keefe, Ibraheem Othman, Man-Chiu Poon, Bruce Ritchie, Charles St-Pierre, Donald Stark, Ellie Tsai

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)

Article Allergy

In Search of an Association Between Genotype and Phenotype in Hereditary Angioedema due to C1-INH Deficiency

David Loli-Ausejo, Alberto Lopez-Lera, Christian Drouet, Marina Lluncor, Elsa Phillips-Angles, Maria Pedrosa, Rosario Cabanas, Teresa Caballero

Summary: This study investigated the genotype/phenotype correlation in adult patients with C1-INH-HAE, finding minimal differences in clinical phenotype among those with different SERPING1 gene mutations, with a tendency for more severe phenotype in class III. Larger multicenter, international studies are proposed to confirm these findings and explore possible genotype/phenotype relationships further.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer-Simons syndrome)

Fernando Corvillo, Laura Gonzalez-Sanchez, Alberto Lopez-Lera, Emilia Arjona, Giovanni Ceccarini, Ferruccio Santini, David Araujo-Vilar, Rebecca J. Brown, Joan Villarroya, Francesc Villarroya, Santiago Rodriguez de Cordoba, Teresa Caballero, Pilar Nozal, Margarita Lopez-Trascasa

Summary: The study found significantly elevated FD levels in BSS patients, with a strong positive correlation between FD and age in BSS. While a positive correlation between FD and C3 was seen in C3G patients, no correlation was detected in BSS. Gene expression studies in BSS adipose tissue showed decreased CFD and C3 levels but elevated C5 transcript levels. This suggests that FD may serve as a reliable diagnostic biomarker for the pathophysiology of BSS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Allergy

Medical algorithm: Management of C1 inhibitor hereditary angioedema

Teresa Caballero, Rosario Cabanas, Maria Pedrosa

ALLERGY (2022)

Article Health Care Sciences & Services

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Neboa Zozaya, Teresa Caballero, Teresa Gonzalez-Quevedo, Pedro Gamboa Setien, Ma Angeles Gonzalez, Ramon Jodar, Jose Luis Poveda-Andres, Encarna Guillen-Navarro, Agustin Rivero Cuadrado, Alvaro Hidalgo-Vega

Summary: This study applied a multicriteria decision analysis to assess the value of three long-term prophylactic therapies for hereditary angioedema (HAE) in Spain. The results showed that lanadelumab was assessed as a high-value intervention, better than C1-INH and substantially better than danazol for LTP treatment of HAE.

GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT (2022)

Review Allergy

The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema

Marcus Maurer, Werner Aberer, Teresa Caballero, Laurence Bouillet, Anete S. Grumach, Jaco Botha, Irmgard Andresen, Hilary J. Longhurst

Summary: This article reviews data from the ongoing Icatibant Outcome Survey (IOS) registry, demonstrating that icatibant is effective in real-world settings and comparable to clinical trial efficacy. The review highlights the importance of early treatment and the effectiveness/safety of icatibant across different patient subgroups.

CLINICAL AND EXPERIMENTAL ALLERGY (2022)

Letter Gastroenterology & Hepatology

Ultrasound findings in an abdominal crisis of a patient with hereditary angioedema

Joaquin Poza Cordon, Pedro de Maria Pallares, Teresa Caballero Molina

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2020)

Meeting Abstract Allergy

A multidisciplinary intervention resulted in improvement in qualilty of life among patients with hereditary angioedema

Adriana Moreno, Fernanda Nunes, Sarah Langer, Mariana Ferriani, Davi Aragon, Teresa Caballero, Luisa Karla Arruda

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Meeting Abstract Biochemistry & Molecular Biology

CHARACTERIZATION OF THE COAGULATION FXII T309K MUTATION IN PATIENTS WITH HEREDITARY ANGIOEDEMA

Maria Eugenia de la Morena Barrio, Raquel Lopez Gavez, Jonas Emsley, Teresa Caballero, Margarita Lopez Trascasa, Javier Corral, Alberto Lopez Lera

MOLECULAR IMMUNOLOGY (2019)

Meeting Abstract Allergy

Determinant factors of disease activity in hereditary angioedema due to C1 inhibitor deficiency

E. Phillips-Angles, M. Lluncor, M. Pedrosa, D. Lamacchia, A. Hernanz, A. Alvez-Liste, N. Prior, R. Cabanas, T. Caballero

ALLERGY (2019)

Meeting Abstract Allergy

Treatment outcomes with high frequency versus low frequency icatibant use in the real-world setting: Results from the icatibant outcome survey

H. J. Longhurst, T. Caballero, W. Aberer, L. Bouillet, A. S. Grumach, J. Botha, I Andresen, M. Maurer

ALLERGY (2019)

Meeting Abstract Allergy

Rapid and sustainable effect of icatibant across recurrent hereditary angioedema attacks in adolescent patients

A. Kessel, H. Farkas, A. Reshef, T. Caballero, M. C. Ortega-Lopez, M. Vardi, J. Hao, W. Aberer

ALLERGY (2019)

Meeting Abstract Allergy

Early treatment with icatibant reduces the time to onset of symptom relief in children and adolescents with hereditary angioedema (HAE)

H. Farkas, M. C. Ortega-Lopez, A. Reshef, A. Kessel, T. Caballero, M. Vardi, J. Hao, W. Aberer

ALLERGY (2019)

暂无数据